Literature DB >> 27808247

Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in a Chinese Tuberculosis Tertiary Care Center.

Hongfei Duan1, Xiqin Han1, Qingfeng Wang1, Jing Wang1, Jun Wang1, Naihui Chu1, Hairong Huang2.   

Abstract

The clinical relevance of non-tuberculous mycobacteria (NTM) has been reported to be different dramatically by species or by regions, however, no such evaluation has been performed in China.A retrospective study was performed in Beijing Chest Hospital. All the NTM strains isolated from respiratory specimens in the past 5 years, and patients' clinical records (symptoms and radiographic information etc.) were investigated. The clinical relevance was evaluated according to the criteria recommended by the American Thoracic society. Totally 232 NTM strains were recruited, among them, M. intracellulare was the dominant species (40.5%), followed by M. abscessus (28.4%). 109 patients, with 185 total isolates, had full clinical records available for review. 84.4% (38/45), 85.7% (24/28%) and 63.6% (7/11) of patients with isolation of M. intracellulare, M. abscessus and M. kansasii, respectively, were categorized as definite NTM disease. Whereas all the 10 patients with isolation of M. gordonae were defined as unlikely NTM disease. The majority of NTMs isolates yielded from respiratory specimens in Beijing Chest Hospital were clinically significant, and M. intracellulare and M. abscessus was the dominated species of NTM lung disease. NTM lung infections demonstrated some specific chest radiograph characteristics.

Entities:  

Mesh:

Year:  2016        PMID: 27808247      PMCID: PMC5093757          DOI: 10.1038/srep36299

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


In recent years, the frequency of nontuberculous mycobacteria (NTM) isolation from respiratory specimens, as well as the number of NTM infection patient, has increased rapidly in many countries12345. Moreover, marked geographic variability was observed regarding both the prevalence of NTM lung disease and the mycobacterial species responsible for it6. Patients with NTM disease are often indistinguishable clinically or radiographically from patients infected with Mycobacterium tuberculosis78910. However, the strategy of treatment and the prognosis of NTM disease can be significantly different from TB, resulting in different implications for public health. In China, tuberculosis remains a serious public health problem and as a consequence, patients with positive outcomes of acid-fast bacilli (AFB) smear test or with isolation of mycobacteria by culture for sputum specimens have been routinely diagnosed as pulmonary tuberculosis and been administrated with anti-tuberculosis drugs11. The extent of misdiagnosis and inappropriate treatment of disease due to NTM infection in China lacks comprehensive understanding. On the other hand, NTM isolation does not affirmatively mean disease, so that the health providers have to stay alert for possible contamination or NTM colonization all the time. Thus the isolation of NTM species may pose a diagnostic difficulty for clinicians. We performed an institution-based observational study for NTM lung disease in Beijing Chest Hospital (Beijing, China), and investigated the clinical, microbiological and radiographic information of possible NTM infection patients from 2010 to 2015. The purpose of the current study was to determine the isolation frequency of different NTM species from respiratory specimen over a 5-year period, and to evaluate their clinical significance.

Materials and Methods

Study subjects

All NTM strains isolated from respiratory specimens in Beijing Chest Hospital over a 5-year period from May 2010 to May 2015 were retrospectively analyzed. The medical records of patients from whom NTM strains isolated were retrospectively reviewed. Informed consent was obtained from all subjects included in the study. The protocols and procedures for the protection of human subjects were approved by the Ethics Committee of Beijing Chest Hospital. Furthermore, all the methods were carried out in accordance with the approved guidelines.

Mycobacterium cultures

Sputum and bronchial washing specimens were decontaminated using the N-acetyl-L-cysteine 2% NaOH method. Löwenstein-Jensen medium culture or liquid culture using MGIT 960 system (BD Biosciences, Sparks, MD, USA), or both methods were performed to recover mycobacteria. Mycobacterial growth in PNB-containing medium was used as a presumptive test for NTM screening.

Identification of NTM species

NTM isolates were identified to the species level by sequence alignment of 16S rDNA, 16-23S rRNA gene internal transcribed spacer (ITS), rpoB and hsp65 genes. Preparation of the PCR amplification and DNA sequencing were done as described previously12.

Clinical significance evaluation of isolated NTM

Patient with clinical record containing symptom, radiographic and microbiological information was considered clinically evaluable and classified as having definite, probable, or unlikely NTM lung disease according to the diagnostic criteria for NTM lung disease issued by American Thoracic Society(ATS) in 200713. Definite NTM disease was defined as (1) Pulmonary symptoms, nodular or cavitary opacities on chest radiograph, or a high-resolution computed tomography scan that showed multifocal bronchiectasis with multiple small nodules; (2) Positive culture results from at least two separate expectorated sputum samples; Positive culture result from at least one bronchial wash or lavage; or transbronchial or other lung biopsy with mycobacterial histopathologic features (granulomatous inflammation or AFB) and positive culture for NTM or biopsy showing mycobacterial histopathologic features (granulomatous inflammation or AFB) and one or more sputum or bronchial washings that are culture positive for NTM; (3) Exclusion of tuberculosis and other illnesses that may produce similar symptoms and signs. Probable NTM disease was diagnosed if the patient met the third criterion and either of the other two criteria for definite NTM disease. NTM disease was judged to be unlikely if the patient did not meet any of the criteria for definite or probable NTM disease. In addition, M. gordonae and M. terrae isolations, well-known environmental contaminants were considered unlikely in relation to the lung diseases regardless of the other manifestations13. Definite and probable NTM lung diseases were regarded as clinically significant NTM lung infection1415.

Radiographic feature analysis of the patients with definite NTM lung disease

Two TB specialists simultaneously analyzed the radiographic features of chest computed tomography (CT) scan. The definite NTM lung disease was classified into three forms, according to CT findings. The upper lobe cavitary form was defined as a combination of cavities, consolidation, and pleural thickening in the upper lobes, regardless of reticulonodular opacities. The nodular bronchiectatic form was defined as unilateral or bilateral bronchiectasis and nodular changes without visible cavities in the upper lobes. For nodular bronchiectatic form, the implication of lingular segment or the right middle lobe was investigated. Patient’s disease remained unclassified if it belonged neither to the upper lobe cavitary nor the nodular bronchiectatic form. In the unclassifiable form, multifocal lobular or segmental consolidations usually comprised the predominant finding13.

Statistical analysis

All statistical analyses were performed using SPSS22.0 software (SPSS Inc., Chicago, IL, USA). Comparisons of categorical variables and numerical variables were performed using the Pearson Chi-squared tests or t-tests respectively. P values of less than 0.05 were considered to indicate statistical significance.

Results

Frequency of isolated NTM species

From May 2010 to May 2015, a total of 232 NTM isolates were reported from respiratory specimens which included M. intracellulare (n = 94, 40.5%), M. abscessus (n = 66, 28.4%), M. kansasii (n = 23, 9.9%), M. fortuitum (n = 20, 8.6%), M. avium (n = 11, 4.7%), M. gordonae (n = 10, 4.3%), M. szulgai (n = 3, 1.3%), M. terrae(n = 2, 0.9%), M. simiae (n = 1, 0.4%), M. parascrofulaceum (n = 1, 0.4%) and M. neoaurum (n = 1, 0.4%). 226 strains were isolated from sputa, 5 strains from bronchial washings and 1 strain from lung tissue.

Clinical significance of NTM isolates

Among those 232 isolates, 109 patients which accounted for 185 NTM isolates had full clinical records available for review. All patients were free of human immunodeficiency virus infection. Patients were then grouped into the three disease categories based on criteria cited above. Of the 109 patients, 72 (66.1%) had definite diseases, 27 (24.8%) had probable disease, and 10 (9.2%) had unlikely disease. M. gordonae was isolated from sputum sample of one patient who acquired M. abscessus-associated lung disease during antibiotic treatment. This strain was excluded from further analysis. The implicated NTM organisms are shown in Table 1.
Table 1

Etiology of Clinically Significant NTM Lung Infection based on per-patient analysis.

OrganismClassification of NTM lung Disease
Definite NTM Lung Disease, No. (%)Probable NTM Lung Disease, No. (%)Unlikely NTM Lung Disease, No. (%)Total, No.
M. intracellulare38 (84.4%)7 (15.6%)045
M. abscessus24 (85.7%)4 (14.3%)028
M. kansasii7 (63.6%)4 (36.4%)011
M. fortuitum08 (100%)08
M. avium2 (33.3%)4 (66.7%)06
M. szulgai1 (100%)001
NTM isolation demonstrated extremely high clinical significance among the 109 enrolled patients as 99 (90.8%) were defined as definite or probable disease. The absolute majority of patients with isolation of M. intracellulare (84.4%), and M. abscessus (85.7%) were finally categorized as definite disease, while all the isolations of M. intracellulare, M. abscessus, M. kansasi, M. kansasii, M. avium and M. szulgai were defined as clinically significant. On the other hand, none of the 10 patients, with M. gordonae isolation, were considered to have relation with disease.

Clinical and radiographic characteristics of patients with definite lung disease

Characteristics of the patients in current study are summarized in Table 2. There were no significant differences in the sex, mean age, body mass index (BMI), presence of underlying disease and symptom among the three groups. Sputum AFB smears were positive for 84.7% (61/72) of the patients with definite NTM lung disease, 67.9% (19/28) with probable disease, whereas only 1 out of the 10 patients with unlikely disease produced positive smear test outcome.
Table 2

Characteristics of 109 patients from whom NTM were isolated.

CharacteristicsClassification of NTM lung Disease
Definite NTM Lung Disease (n = 72)Probable NTM Lung Disease(n = 27)Unlikely NTM Lung Disease (n = 10)
Male38145
Mean age (y) ± SD54.1 ± 22.551.8 ± 24.051.5 ± 24.1
BMI, kg/m222.3 ± 2.724.0 ± 2.623.9 ± 2.8
Underlying Disease   
 Previous tuberculosis1130
 COPD643
 Bronchiectasis521
 Silicosis200
 Diabetes Mellitus421
 Other disease200
 Previous steroid treatment200
 Smoker744
Positive sputum AFB smear*61191
Symptom   
 Cough72249
 Productive cough35134
 Hemoptysis2591
 Constitutional symptom410
Type of disease   
 Nodular bronchiectatic form41141
 Upper lobe cavitary form2950
 Unclassifiable form*289

*P < 0.05.

Among 72 patients with definite NTM disease, 29 had the upper lobe cavitary form (Figs 1, 2, 3), 41 patients had nodular bronchiectatic form (Figs 4 and 5), whereas 2 patients possessed the unclassifiable form (Table 3). For 27 cases with probable NTM lung disease, 8 cases classified as unclassifiable form. Whereas among the 10 cases with unlikely NTM lung disease, 9 of had unclassifiable form. For nodular bronchiectatic form patients, M. intracellulare lung disease had more tendency to infect the lingular segment and the right middle lobe compared with M. abscessus lung disease (72.7% (16/22) vs 26.3% (5/19), p < 0.05).
Figure 1

M. intracellulare lung disease in a 68-year-old man.

Chest CT scan shows large multi-cavitary lesions in bilateral upper lobes and pleural thickness.

Figure 2

M. kansasii lung disease in a 46-year-old man.

Chest CT scan shows a cavity and centrilobular nodules in right upper lobe.

Figure 3

M. szulgai lung disease in a 38-year-old man.

Chest CT scan shows a large cavity and centrilobular nodules in left upper lobe and pleural thickness.

Figure 4

M. intracellulare lung disease in a 57-year-old woman.

Chest CT scan shows centrilobular nodules and bronchiectasis. Also note lesions predominate in lingular segment and right middle lobe.

Figure 5

M. abscessus lung disease in a 62-year-old woman.

Chest CT scan shows centrilobular nodules and bronchiectasis. Also note lesions without segment or lobe predominance.

Table 3

Characteristics of 72 patients with definite NTM lung disease according to species.

CharacteristicsEtiology of NTM lung Disease
M. intracellulare (n = 38)M. abscessus (n = 24)M.kansasii (n = 7)M.avium (n = 2)M.szulgai (n = 1)
Male219511
Mean age (y) ± SD52.1 ± 16.546.8 ± 17.153.5 ± 10.938.641
BMI, kg/m221.2 ± 1.623.0 ± 2.122.7 ± 2.722.520.1
Underlying Disease     
 Previous tuberculosis64100
 COPD32010
 Bronchiectasis22010
 Silicosis20000
 Diabetes Mellitus22000
 Other disease20000
 Previous steroid treatment20000
 Previous smoking61000
Positive sputum AFB smear3221611
Symptom     
 Cough3824721
 Productive cough1513511
 Hemoptysis155320
 Constitutional symptom31000
Type of disease     
 Nodular bronchiectatic form2219000
 Upper lobe cavitary form163721
 Unclassifiable form02000

Discussion

NTM have been implicated in an increasingly large proportion of pulmonary disease throughout the world, in both immunocompetent and immunocompromised hosts16171819. In many countries, MAC (including M. intracellulare and M. avium) are the most common NTM isolates. On the other hand, M. avium is predominant in North- and South America, M. intracellulare is most frequently isolated in Australia-Queensland, South Africa and some provinces in China6202122. Our study showed that M. intracellulare was the most common species of NTM isolation, followed by M. abscessus in Beijing Chest Hospital which is located in north of China. It is believed that NTM disease is under-reported in the tuberculosis-endemic countries. The main reason could be the high burden of tuberculosis which attracts bulk of the attention of clinicians. In our knowledge, this is the first research to document the clinical significance of NTM isolates from respiratory specimens in China, a high TB burden country. The major findings of this study are as following: (1) NTM strains isolated from respiratory specimens demonstrated very good relation with lung infections (90.9%). (2) M. intracellulare was the most common NTM species (40.5%) isolated from clinical respiratory specimens, and it was also the most common pathogen (52.8%) of NTM lung disease in our institution. Although in some areas M. intracellulare is less likely to cause NTM lung disease23, our data demonstrated that M. intracellulare is the predominant bacteria for NTM lung disease in Beijing Chest Hospital. (3) M. abscessus was the second most commonly isolated species (28.4%) and represented the second most common pathogen (33.3%). Since M. intracellulare and M. abscessus lung diseases had the most poor prognosis among all the NTM lung diseases, according to our outcomes, the NTM lung disease treatment will be very challenging in China as those two species account for the majority of NTM lung diseases1324. Although the incidence of pulmonary disease caused by M. kansasii is the second most common (approximately 20%) type of NTM pulmonary disease in Japan and USA2526, it is uncommon in our institution. However, in Shanghai, another industrialized city in the south of China, M. kansasii is the most frequently identified isolate, accounting for 45% of all NTM isolates20. It seems that geographic distribution of NTM species is significantly different in a large country like China. Among the definite, probable and unlikely NTM lung disease, there were no significant differences in the sex, mean age, BMI, presence of underlying disease and symptoms, but fewer patients with unlikely NTM lung disease were sputum AFB smear positive. It is possible that unlikely NTM lung diseases have less bacterial load, however with a more sensitive method, such as liquid culture, the chances to recover it can increase. 8 out of the 10 unlikely NTM infection cases had isolations recovered by MGIT960 only, which was consistent with this assumption. At a hospital in USA, the dramatic increase of NTM isolation was attributed to the more sensitive liquid culture technique, which led to less clinical significance of NTM isolations27. All the 10 unlikely NTM lung disease cases had the isolations of M. gordonae in this study, which warns clinicians to interpret NTM recovery by MGIT960 systems with cautions, especially for M. gordonae. Compared with reports from other countries141523, nearly 66.1% of the patients with NTM isolations were diagnosed as definite NTM disease in this assay, which is much higher than those of most other studies. Furthermore, we speculated that some more patients with possible NTM lung disease due to less bacterial evidence would fulfill the definite NTM lung disease criteria during the follow-up process. We attributed the tight relationship of NTM isolation with lung infection mainly to more severe cases enrolled in the study. Our institution is the top tuberculosis referral center in China and has admitted various patients with serious symptoms transferred from other hospitals. In addition, another contributing factor may be that clinicians in our hospital were very knowledgeable of NTM disease, hence they regularly prescribed repeated mycobacterium culture for suspected NTM disease patients. The only species we did not find good clinical significance was M. fortuitum. A study in Japan also found that among 26 patients with a minimum of two M. fortuitum isolations, none showed clinical aggravation during the follow-up period28. It is likely that colonization or contamination during culture happens frequently with this species. NTM lung infection may have some specific image characteristics for a CT scan. Among patients with definite NTM lung disease, fewer cases have unclassifiable form for radiographic features compared with patients with probable and unlikely NTM disease. Based on our research, cases without typical nodular bronchiectatic and upper lobe cavitary forms are less likely to be related to NTM lung disease. The position of nodular bronchiectatic lesion demonstrated species-specific characteristics. M. intracellulare lung diseases were more likely to be implicated in the lingular segment and the right middle lobe in contrast with M. abscessus lung diseases.

Conclusions

In conclusion, a substantial proportion (90.9%) of patients, from whom NTM isolates were recovered, exhibited definite or probable NTM lung disease in our institution. The most common etiologies of NTM lung disease included M. intracellulare and M. abscessus. NTM lung infections frequently demonstrated the upper lobe cavitary form or nodular bronchiectatic form for chest radiograph examination. However, as NTM only accounted for 2.6% of all the mycobacterial isolations in our hospital according to previous work29, the clinical significance in other areas of China with high percentages of NTM isolation and different species constitutions might be different with our conclusions, but more investigations need be done to prove this assumption.

Additional Information

How to cite this article: Duan, H. et al. Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in a Chinese Tuberculosis Tertiary Care Center. Sci. Rep. 6, 36299; doi: 10.1038/srep36299 (2016). Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
  28 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

3.  Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?

Authors:  G Badoum; N Saleri; M S Dembélé; M Ouedraogo; G Pinsi; K Boncoungou; V Bonkoungou; E Birba; P Miotto; G B Migliori; D M Cirillo; A Matteelli
Journal:  Eur Respir J       Date:  2011-05       Impact factor: 16.671

4.  Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease.

Authors:  Won-Jung Koh; Byeong-Ho Jeong; Kyeongman Jeon; Nam Yong Lee; Kyung Soo Lee; Sook Young Woo; Sung Jae Shin; O Jung Kwon
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

5.  Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.

Authors:  Emily Henkle; Katrina Hedberg; Sean Schafer; Shannon Novosad; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2015-05

6.  Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands.

Authors:  J van Ingen; S A Bendien; W C M de Lange; W Hoefsloot; P N R Dekhuijzen; M J Boeree; D van Soolingen
Journal:  Thorax       Date:  2009-02-12       Impact factor: 9.139

7.  The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Authors:  Wouter Hoefsloot; Jakko van Ingen; Claire Andrejak; Kristian Angeby; Rosine Bauriaud; Pascale Bemer; Natalie Beylis; Martin J Boeree; Juana Cacho; Violet Chihota; Erica Chimara; Gavin Churchyard; Raquel Cias; Rosa Daza; Charles L Daley; P N Richard Dekhuijzen; Diego Domingo; Francis Drobniewski; Jaime Esteban; Maryse Fauville-Dufaux; Dorte Bek Folkvardsen; Noel Gibbons; Enrique Gómez-Mampaso; Rosa Gonzalez; Harald Hoffmann; Po-Ren Hsueh; Alexander Indra; Tomasz Jagielski; Frances Jamieson; Mateja Jankovic; Eefje Jong; Joseph Keane; Wo-Jung Koh; Berit Lange; Sylvia Leao; Rita Macedo; Turid Mannsåker; Theodore K Marras; Jeannette Maugein; Heather J Milburn; Tamas Mlinkó; Nora Morcillo; Kozo Morimoto; Dimitrios Papaventsis; Elia Palenque; Mar Paez-Peña; Claudio Piersimoni; Monika Polanová; Nalin Rastogi; Elvira Richter; Maria Jesus Ruiz-Serrano; Anabela Silva; M Pedro da Silva; Hulya Simsek; Dick van Soolingen; Nora Szabó; Rachel Thomson; Teresa Tórtola Fernandez; Enrico Tortoli; Sarah E Totten; Greg Tyrrell; Tuula Vasankari; Miguel Villar; Renata Walkiewicz; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

8.  A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan.

Authors:  Kozo Morimoto; Kazuro Iwai; Kazuhiro Uchimura; Masao Okumura; Takashi Yoshiyama; Kozo Yoshimori; Hideo Ogata; Atsuyuki Kurashima; Akihiko Gemma; Shoji Kudoh
Journal:  Ann Am Thorac Soc       Date:  2014-01

9.  Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study.

Authors:  Jie Wu; Yangyi Zhang; Jing Li; Senlin Lin; Lili Wang; Yuan Jiang; Qichao Pan; Xin Shen
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

10.  The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China.

Authors:  Yan Shao; Cheng Chen; Honghuan Song; Guoli Li; Qiao Liu; Yan Li; Limei Zhu; Leonardo Martinez; Wei Lu
Journal:  PLoS Negl Trop Dis       Date:  2015-03-16
View more
  9 in total

1.  Diversity of Nontuberculous Mycobacteria in Kuwait: Rapid Identification and Differentiation of Mycobacterium Species by Multiplex PCR, INNO-LiPA Mycobacteria v2 Assay and PCR Sequencing of rDNA.

Authors:  Suhail Ahmad; Eiman Mokaddas
Journal:  Med Princ Pract       Date:  2019-02-14       Impact factor: 1.927

Review 2.  Non-tuberculous mycobacteria immunopathogenesis: Closer than they appear. a prime of innate immunity trade-off and NTM ways into virulence.

Authors:  Marisa Cruz-Aguilar; Antonia I Castillo-Rodal; René Arredondo-Hernández; Yolanda López-Vidal
Journal:  Scand J Immunol       Date:  2021-06-22       Impact factor: 3.889

3.  High rates of nontuberculous mycobacteria isolation from patients with presumptive tuberculosis in Iran.

Authors:  M J Nasiri; H Dabiri; A A I Fooladi; S Amini; G Hamzehloo; M M Feizabadi
Journal:  New Microbes New Infect       Date:  2017-09-06

4.  Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital.

Authors:  H F Schiff; S Jones; A Achaiah; A Pereira; G Stait; B Green
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

5.  Evaluating the clinical significance of nontuberculous mycobacteria isolated from respiratory samples in Iran: an often overlooked disease.

Authors:  Zahra Mortazavi; Ahmadreza Bahrmand; Fatemeh Sakhaee; Reza Hosseini Doust; Farzam Vaziri; Seyed Davar Siadat; Abolfazl Fateh
Journal:  Infect Drug Resist       Date:  2019-07-03       Impact factor: 4.003

6.  Disseminated Coinfection by Mycobacterium fortuitum and Talaromyces marneffei in a Non-HIV Case.

Authors:  Hongchun Huang; Jingmin Deng; Caixia Qin; Jianpeng Zhou; Minchao Duan
Journal:  Infect Drug Resist       Date:  2021-09-07       Impact factor: 4.003

7.  Identification and characterization of nontuberculous mycobacteria isolated from suspected pulmonary tuberculosis patients in eastern china from 2009 to 2019 using an identification array system.

Authors:  Yelei Zhu; Wenya Hua; Zhengwei Liu; Mingwu Zhang; Xiaomeng Wang; Beibei Wu; Zhen Wang; Jiazhen Chen
Journal:  Braz J Infect Dis       Date:  2022-03-11       Impact factor: 3.257

8.  A glimpse into the genotype and clinical importance of non tuberculous mycobacteria among pulmonary tuberculosis patients: The case of Ethiopia.

Authors:  Alem Alemayehu; Abebaw Kebede; Sebsib Neway; Efrem Tesfaye; Betselot Zerihun; Melak Getu; Beyene Petros
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

9.  An Intensified Regimen Containing Linezolid Could Improve Treatment Response in Mycobacterium abscessus Lung Disease.

Authors:  Hua Li; Li Tong; Jun Wang; Qingtao Liang; Yun Zhang; Naihui Chu; Xiaoyou Chen; Hongfei Duan
Journal:  Biomed Res Int       Date:  2019-11-19       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.